<p>如今，簡單購買指數基金很容易，你的回報應該（大致上）與市場相匹配。但通過選擇表現優於平均水平的股票，你可以顯著提高回報。例如，<strong>Insulet Corporation</strong>（NASDAQ:PODD）的股價在過去一年上漲了 47%，明顯超過了市場約 10% 的回報（不包括股息）。這應該讓股東們感到高興。話雖如此，長期回報並不那麼令人印象深刻，三年內股價僅上漲了 25%。</p>
<p>所以讓我們調查一下，看看公司的長期表現是否與其基本業務的進展相符。</p>
<p>這項技術可能會取代計算機：發現 20 只正在努力使量子計算成為現實的股票。</p>
<p>在他的文章《格雷厄姆與多德斯維爾的超級投資者》中，沃倫·巴菲特描述了股價並不總是理性地反映企業價值的情況。一種有缺陷但合理的評估公司情緒變化的方法是將每股收益（EPS）與股價進行比較。</p>
<p>在過去一年中，Insulet 的每股收益（EPS）增長了 102%。可以公平地説，47% 的股價漲幅並沒有跟上 EPS 的增長。因此，儘管有增長，市場似乎對 Insulet 的熱情有所降温。有趣。</p>
<p>下圖顯示了 EPS 隨時間的變化情況（如果你點擊圖片，可以看到更詳細的信息）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/618908-earnings-per-share-growth-1-dark/1746368058388?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/618908-earnings-per-share-growth-1-dark/1746368058388"/></p>
<p>NasdaqGS:PODD 每股收益增長 2025 年 5 月 4 日</p>
<p>當然，看到 Insulet 多年來的利潤增長是非常好的，但未來對股東來説更為重要。如果你考慮購買或出售 Insulet 的股票，你應該查看這份 <strong>免費</strong> 的詳細資產負債表報告。</p>
<h2>不同的視角</h2>
<p>我們很高興地報告，Insulet 的股東在一年內獲得了 47% 的總股東回報。這比過去五年年化回報 3% 要好，暗示公司最近表現更佳。持樂觀態度的人可能會將最近的 TSR 改善視為企業本身隨着時間的推移而變得更好的跡象。如果你想更詳細地研究 Insulet，可能想看看內部人士是否在買入或賣出公司的股票。</p>
<p>如果你更願意查看另一家公司——一家可能財務狀況更優越的公司——那麼不要錯過這份 <strong>免費</strong> 的公司名單，這些公司已經證明它們能夠實現盈利增長。</p>
<p><em>請注意，本文中引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。</em></p>
<p>如果你想交易 Insulet，請在專業人士信任的最低成本平台 Interactive Brokers 開設賬户。</p>
<p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓你可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
<p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠遠優於大多數經紀商提供的服務。</p>
<p>贊助內容</p>

PODD

<p>一年前投資 Insulet（NASDAQ:PODD）將獲得 47% 的收益，超過市場 10% 的回報。儘管如此，該股票的長期表現僅在三年內增長了 25%。Insulet 的每股收益（EPS）在過去一年增長了 102%，這表明股價並未跟上其增長步伐。儘管近期回報令人鼓舞，但過去五年的整體年化回報僅為 3%。投資者在做出決策之前，建議考慮公司的資產負債表和內部交易活動</p>

<p>These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can significantly boost your returns by picking above-average stocks. For example, the <strong>Insulet Corporation</strong> (NASDAQ:PODD) share price is up 47% in the last 1 year, clearly besting the market return of around 10% (not including dividends). So that should have shareholders smiling. Having said that, the longer term returns aren't so impressive, with stock gaining just 25% in three years.</p>
<div class="lb-trans"><p>如今，簡單購買指數基金很容易，你的回報應該（大致上）與市場相匹配。但通過選擇表現優於平均水平的股票，你可以顯著提高回報。例如，<strong>Insulet Corporation</strong>（NASDAQ:PODD）的股價在過去一年上漲了 47%，明顯超過了市場約 10% 的回報（不包括股息）。這應該讓股東們感到高興。話雖如此，長期回報並不那麼令人印象深刻，三年內股價僅上漲了 25%。</p>
</div><p>So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.</p>
<div class="lb-trans"><p>所以讓我們調查一下，看看公司的長期表現是否與其基本業務的進展相符。</p>
</div><p>This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.</p>
<div class="lb-trans"><p>這項技術可能會取代計算機：發現 20 只正在努力使量子計算成為現實的股票。</p>
</div><p>In his essay <em>The Superinvestors of Graham-and-Doddsville</em> Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.</p>
<div class="lb-trans"><p>在他的文章《格雷厄姆與多德斯維爾的超級投資者》中，沃倫·巴菲特描述了股價並不總是理性地反映企業價值的情況。一種有缺陷但合理的評估公司情緒變化的方法是將每股收益（EPS）與股價進行比較。</p>
</div><p>During the last year Insulet grew its earnings per share (EPS) by 102%. It's fair to say that the share price gain of 47% did not keep pace with the EPS growth. So it seems like the market has cooled on Insulet, despite the growth. Interesting.</p>
<div class="lb-trans"><p>在過去一年中，Insulet 的每股收益（EPS）增長了 102%。可以公平地説，47% 的股價漲幅並沒有跟上 EPS 的增長。因此，儘管有增長，市場似乎對 Insulet 的熱情有所降温。有趣。</p>
</div><p>The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).</p>
<div class="lb-trans"><p>下圖顯示了 EPS 隨時間的變化情況（如果你點擊圖片，可以看到更詳細的信息）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/618908-earnings-per-share-growth-1-dark/1746368058388" alt="" original-src="https://images.simplywall.st/asset/chart/618908-earnings-per-share-growth-1-dark/1746368058388"/></p>
<p>NasdaqGS:PODD Earnings Per Share Growth May 4th 2025</p>
<div class="lb-trans"><p>NasdaqGS:PODD 每股收益增長 2025 年 5 月 4 日</p>
</div><p>It is of course excellent to see how Insulet has grown profits over the years, but the future is more important for shareholders. If you are thinking of buying or selling Insulet stock, you should check out this <strong>FREE</strong> detailed report on its balance sheet.</p>
<div class="lb-trans"><p>當然，看到 Insulet 多年來的利潤增長是非常好的，但未來對股東來説更為重要。如果你考慮購買或出售 Insulet 的股票，你應該查看這份 <strong>免費</strong> 的詳細資產負債表報告。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的視角</h2>
</div><p>We're pleased to report that Insulet shareholders have received a total shareholder return of 47% over one year. That's better than the annualised return of 3% over half a decade, implying that the company is doing better recently. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. If you would like to research Insulet in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.</p>
<div class="lb-trans"><p>我們很高興地報告，Insulet 的股東在一年內獲得了 47% 的總股東回報。這比過去五年年化回報 3% 要好，暗示公司最近表現更佳。持樂觀態度的人可能會將最近的 TSR 改善視為企業本身隨着時間的推移而變得更好的跡象。如果你想更詳細地研究 Insulet，可能想看看內部人士是否在買入或賣出公司的股票。</p>
</div><p>If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this <strong>free</strong> list of companies that have proven they can grow earnings.</p>
<div class="lb-trans"><p>如果你更願意查看另一家公司——一家可能財務狀況更優越的公司——那麼不要錯過這份 <strong>免費</strong> 的公司名單，這些公司已經證明它們能夠實現盈利增長。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.</em></p>
<div class="lb-trans"><p><em>請注意，本文中引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。</em></p>
</div><p>If you're looking to trade Insulet, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果你想交易 Insulet，請在專業人士信任的最低成本平台 Interactive Brokers 開設賬户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓你可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠遠優於大多數經紀商提供的服務。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>贊助內容</p>
</div>

如果一年前投資 Insulet（NASDAQ:PODD），您將獲得 47% 的收益